Terumo Cardiovascular Group: Ann Arbor Firm Helps Release Critical Product to Oxygenate Blood in COVID-19 Patients

Terumo Cardiovascular, an Ann Arbor-based global company that offers cardiovascular surgery technologies, is collaborating to sell CytoSorb to hospitals in Alabama, Arizona, California, Georgia, Louisiana, Mississippi, New Mexico, Oregon, Texas, and Washington. CytoSorb is an extracorporeal cytokine absorber, an integral part of the technology, that received Emergency Use Authorization by the U.S. Food and Drug [...]The post Ann Arbor Firm Helps Release Critical Product to Oxygenate Blood in COVID-19 Patients appeared first on DBusiness Magazine.